Endpoints News featured commentary from Mitchell Clough in an article about the impending deadline for two major drugmakers to appeal Inflation Reduction Act challenges to the US Supreme Court as the first set of negotiated Medicare drug prices is scheduled to take effect on January 1, 2026. While many experts doubt that the Supreme Court will intervene before the January deadline, companies may still hope for eventual rulings that could invalidate or reshape the program.

“If [the drugmakers] get a decision, even a year from now, to preclude these prices from being enforced in the longer term, that’s obviously still a victory for them,” Mitchell says.

Source

Endpoints News